MedTrace Logo

SINUS WASH Pilot Study in Adults Testing Positive for COVID-19

NCT04393792 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-09-17

No results posted yet for this study

Summary

COVID-19 is highly infectious and transmission of the virus is thought to be similar to that of influenza which can be transferred through droplets released when a person coughs, sneezes or talks. Studies have shown that nasal rinsing and mouth washes may be an important way to deliver treatments that could reduce the amount of a virus that is present in the nose and mouth. This also could mean that there is less virus available to pass on to others. We want to see if the use of nose rinses and mouth washes using Povidone-Iodine will reduce the the amount of virus in the nose and throat of people who have tested positive for COVID-19 disease and also reduce the spread of infection within their household.

Conditions

  • Coronavirus Infection

Interventions

DRUG

Povidone-Iodine

0.23% three times daily (tds) for 3 days

DRUG

Normal saline

0.9% three times daily (tds) for 3 days

Sponsors & Collaborators

  • Hampshire Hospitals NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Afroze Khan, MBBS MRCS · Hampshire Hospitals NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-05
Primary Completion
2022-03-31
Completion
2022-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04393792 on ClinicalTrials.gov